Skip to main content

Tyra Biosciences, Inc.

TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001863127

In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Tyra Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $20.0K in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$20.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Tyra Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Tyra Biosciences, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Harris ToddPresident and CEO1,438,495Sep 17, 20263
Rueb YuliyaVice President, Finance (PAO)11,258Sep 17, 20262
Fuhrman AlanChief Financial Officer37,115Sep 17, 20263
RA Capital Healthcare Fund LPDirector, 10% Owner10,259,291IndirectSep 17, 20262
Ra Capital Management, L.P.Director, 10% Owner10,259,291IndirectSep 17, 20262
Kolchinsky PeterDirector, 10% Owner10,259,291IndirectSep 17, 20262
Shah Rajeev M.Director, 10% Owner10,259,291IndirectSep 17, 20262
RA Capital Nexus Fund, L.P.Director10,259,291IndirectSep 17, 20262
Verjee RehanDirector972Sep 11, 20262
More Robert JDirector3,823,425IndirectJun 1, 20263
Gulfo Adele M.Director–Jun 1, 20261
Moran SusanDirector–Jun 1, 20261
Simson JakeDirector–Jun 1, 20261
Rothenberg Stephen MichaelDirector–Jun 1, 20261
Ashar BhaveshChief Operating Officer15,013May 7, 20262
Warner Douglas JChief Medical Officer25,000May 7, 20261
Dable Habib JDirector–Apr 20, 20261
Kaplan GillaDirector28,231Mar 27, 20261
Bensen DanielChief Discovery Officer146,981Feb 13, 20265
Kjellson Nina SDirector443,885IndirectFeb 7, 20250
Boxer Capital Management, LLCOther: See remarks4,448,359IndirectOct 22, 20240
Subramony SiddarthDirector, 10% Owner–May 31, 20240
Tada HiroomiChief Medical Officer86,435Mar 19, 20240
Lewis JosephOther: See Remarks85,939IndirectFeb 8, 20240
Boxer Asset Management Inc.Other: See Remarks85,939IndirectFeb 8, 20240
Boxer Capital, LLCOther: See Remarks85,939IndirectFeb 8, 20240
Davis Aaron I.Other: See Remarks85,939IndirectFeb 8, 20240
MVA Investors, LLCOther: See Remarks85,939IndirectFeb 8, 20240
Chen IsanDirector192,783Jun 2, 20230
Patel Piyush R.Chief Development Officer73,794Feb 23, 20230
van den Boom EstherChief Financial Officer121,897Sep 19, 20220
Hudkins Robert L.Chief Technology Officer273,576Sep 19, 20220
Swanson Ronald V.Chief Scientific Officer273,254Sep 8, 20220
Fawaz Ali D.General Counsel and Secretary–May 16, 20220
Cormorant Asset Management, LPOther: Former 10% Owner1,069,932IndirectSep 21, 20210
Chen BihuaDirector, Other: Former 10% Owner1,069,932IndirectSep 21, 20210
Cormorant Global Healthcare Master Fund, LPOther: Former 10% Owner1,069,932IndirectSep 21, 20210
Cormorant Private Healthcare Fund III LPOther: Former 10% Owner1,069,932IndirectSep 21, 20210
Canaan XI L.P.10% Owner473,396Sep 20, 20210
Canaan Partners XI LLC10% Owner473,396Sep 20, 20210
Canaan Partners 2020+ Co-Investment LLC10% Owner473,396Sep 20, 20210
Canaan 2020+ Co-Investment L.P. Series 710% Owner473,396Sep 20, 20210
Janney Daniel10% Owner4,080,296IndirectSep 17, 20210
Hudson Peter A10% Owner4,080,296IndirectSep 17, 20210
Alta Partners NextGen Fund II, L.P.10% Owner4,080,296IndirectSep 17, 20210
Alta Partners NextGen Fund II Management, LLC10% Owner4,080,296IndirectSep 17, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 17, 2026 (view filing)4:31 PM ETSep 152 daysRA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchase+9.08M$22.03+$200.0M–11.6M afterDerivative
Sep 11, 2026 (view filing)4:30 PM ETSep 92 daysVerjee RehanDirectorPPurchase+971.89$20.58+$20.0KNew position971.89 after
Mar 27, 2026 (view filing)Mar 252 daysKaplan GillaDirectorSSale−14.3K$36.97−$528.5K−33.6%28.2K after
Feb 13, 2026 (view filing)Feb 121 dayBensen DanielChief Discovery OfficerSSale−8.00K$32.87−$263.0K−5.2%147.0K after2 lots10b5-1
Jan 20, 2026 (view filing)Jan 128 daysLateBensen DanielChief Discovery OfficerSSale−8.00K$28.52−$228.2K−4.9%155.0K after2 lots10b5-1
Dec 19, 2025 (view filing)Dec 19Same dayMore Robert JDirectorSSale−10.0K$25.00−$250.0K−0.3%3.82M after10b5-1
Dec 16, 2025 (view filing)Dec 124 daysBensen DanielChief Discovery OfficerSSale−8.00K$22.64−$181.1K−4.7%163.0K after10b5-1
Nov 25, 2025 (view filing)Nov 214 daysMore Robert JDirectorSSale−246.9K$20.25−$5.00M−6.1%3.83M after10b5-1
Nov 19, 2025 (view filing)Nov 18-191 dayBensen DanielChief Operating OfficerSSale−125.6K$16.17−$2.03M−42.3%171.0K after2 lots10b5-1
Nov 17, 2025 (view filing)Nov 13-174 daysBensen DanielChief Operating OfficerSSale−131.4K$16.04−$2.11M−30.7%296.6K after4 lots10b5-1
Jun 20, 2025 (view filing)Jun 17-183 daysKaplan GillaDirectorSSale−9.58K$9.78−$93.7K−25.3%28.2K after2 lots
Jun 16, 2025 (view filing)8:06 PM ETJun 12-164 daysRA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchase+163.3K$10.19+$1.66M+1.6%10.3M after3 lots
Jun 16, 2025 (view filing)Jun 12-164 daysKaplan GillaDirectorSSale−51.8K$10.32−$534.7K−57.8%37.8K after3 lots
Jun 11, 2025 (view filing)7:44 PM ETJun 92 daysRA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchase+186.8K$10.19+$1.90M+1.9%10.1M after
Jun 6, 2025 (view filing)4:43 PM ETJun 4-52 daysRA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchase+1.21M$9.70+$11.8M+13.9%9.91M after2 lots
Feb 7, 2025 (view filing)Feb 52 daysKjellson Nina SDirectorSSale−5.40K$13.76−$74.3K−1.2%443.9K after2 lots
Jan 27, 2025 (view filing)Jan 234 daysKjellson Nina SDirectorSSale−4.83K$16.26−$78.5K−0.1%3.70M after
Jan 21, 2025 (view filing)Jan 16-215 daysKjellson Nina SDirectorSSale−25.0K$16.36−$409.7K−0.7%3.71M after5 lots
Nov 26, 2024 (view filing)Nov 251 dayKjellson Nina SDirectorSSale−5.27K$16.84−$88.8K−1.2%448.7K after2 lots
Nov 13, 2024 (view filing)5:00 PM ETNov 85 daysRA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchase+1.22M$16.25+$19.8M+16.3%8.70M after
Nov 8, 2024 (view filing)Nov 6-72 daysKjellson Nina SDirectorSSale−74.6K$17.22−$1.28M−14.2%449.3K after4 lots
Nov 6, 2024 (view filing)Nov 4-52 daysKjellson Nina SDirectorSSale−11.6K$16.79−$194.3K−2.5%457.3K after4 lots
Nov 1, 2024 (view filing)Oct 30-Nov 12 daysKjellson Nina SDirectorSSale−138.1K$16.45−$2.27M−23.1%458.5K after7 lots
Nov 1, 2024 (view filing)Nov 1Same dayKjellson Nina SDirectorSSaleCommmon Stock−604$17.16−$10.4K0.0%3.81M after
Nov 1, 2024 (view filing)Oct 302 daysFuhrman AlanChief Financial OfficerPPurchase+9.50K$16.00+$152.0K+283.7%12.8K after
Oct 22, 2024 (view filing)Oct 18-214 daysHarris ToddPresident and CEOSSale−62.7K$27.28−$1.71M−4.4%1.36M after3 lots10b5-1
Oct 17, 2024 (view filing)Oct 15-172 daysHarris ToddPresident and CEOSSale−58.7K$25.77−$1.51M−4.0%1.42M after6 lots10b5-1
Oct 2, 2024 (view filing)Sep 302 daysHarris ToddPresident and CEOSSale−500$24.00−$12.0K0.0%1.48M after10b5-1
Sep 25, 2024 (view filing)Sep 23-252 daysHarris ToddPresident and CEOSSale−11.7K$24.11−$283.3K−0.8%1.48M after3 lots10b5-1
Sep 20, 2024 (view filing)Sep 18-202 daysHarris ToddPresident and CEOSSale−16.3K$24.19−$394.4K−1.1%1.49M after4 lots10b5-1
Jun 10, 2024 (view filing)Jun 7-103 daysBensen DanielChief Operating OfficerSSale−3.70K$20.00−$74.0K−0.9%428.0K after2 lots10b5-1
Mar 13, 2024 (view filing)Mar 112 daysBensen DanielChief Operating OfficerSSale−200$20.00−$4.00K0.0%431.7K after10b5-1
Mar 8, 2024 (view filing)Mar 6-72 daysBensen DanielChief Operating OfficerSSale−1.80K$20.09−$36.2K−0.4%431.9K after2 lots10b5-1
Mar 5, 2024 (view filing)Mar 1-54 daysBensen DanielChief Operating OfficerSSale−9.15K$20.06−$183.6K−2.1%433.7K after3 lots10b5-1
Feb 29, 2024 (view filing)Feb 27-292 daysBensen DanielChief Operating OfficerSSale−8.64K$20.09−$173.6K−1.9%442.8K after3 lots10b5-1
Feb 14, 2024 (view filing)Feb 122 daysBensen DanielChief Operating OfficerSSale−1.50K$20.00−$30.0K−0.3%451.5K after10b5-1
Feb 9, 2024 (view filing)Feb 72 daysBensen DanielChief Operating OfficerSSale−9.59K$18.09−$173.4K−2.1%453.0K after10b5-1
Feb 6, 2024 (view filing)Feb 2-64 daysBensen DanielChief Operating OfficerSSale−90.8K$16.63−$1.51M−16.4%462.6K after3 lots10b5-1
Feb 6, 2024 (view filing)Feb 2-54 daysHarris ToddPresident and CEOSSale−100.0K$16.56−$1.66M−6.2%1.50M after3 lots10b5-1
Jul 21, 2023 (view filing)Jul 19-212 daysBensen DanielChief Operating OfficerSSale−4.11K$16.01−$65.8K−0.8%528.0K after2 lots10b5-1
Jul 17, 2023 (view filing)Jul 13-174 daysBensen DanielChief Operating OfficerSSale−2.40K$16.05−$38.5K−0.5%528.0K after2 lots10b5-1
Jul 12, 2023 (view filing)Jul 10-122 daysBensen DanielChief Operating OfficerSSale−1.90K$16.04−$30.5K−0.4%528.0K after3 lots10b5-1
Jul 3, 2023 (view filing)Jun 29-Jul 34 daysBensen DanielChief Operating OfficerSSale−40.4K$16.70−$674.1K−7.1%528.0K after4 lots10b5-1
Jun 28, 2023 (view filing)Jun 26-282 daysBensen DanielChief Operating OfficerSSale−46.8K$16.86−$788.7K−8.1%528.0K after5 lots10b5-1
Jun 26, 2023 (view filing)Jun 22-234 daysHarris ToddChief Executive OfficerSSale−24.2K$17.01−$411.5K−1.5%1.60M after4 lots10b5-1
Jun 21, 2023 (view filing)Jun 16-215 daysHarris ToddChief Executive OfficerSSale−75.8K$17.12−$1.30M−4.5%1.63M after7 lots10b5-1
Jun 15, 2023 (view filing)Jun 13-152 daysHarris ToddChief Executive OfficerSSale−20.7K$16.08−$332.9K−1.2%1.70M after2 lots10b5-1
Jun 15, 2023 (view filing)Jun 13-152 daysBensen DanielChief Operating OfficerSSale−18.3K$16.11−$295.4K−3.4%528.0K after3 lots10b5-1
Apr 5, 2023 (view filing)Apr 32 daysHarris ToddChief Executive OfficerSSale−2.00K$16.13−$32.3K−0.1%1.70M after10b5-1
Apr 3, 2023 (view filing)Mar 30-Apr 34 daysBensen DanielChief Operating OfficerSSale−4.40K$16.08−$70.7K−0.8%528.0K after3 lots10b5-1